Catalan Life Sciences Database

News in the Life Sciences Industry
Results 81 - 100 out of 156 displayed.
« 1 2 3 4 5 6 7 8 »

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

By: GlobenewsWire - 11 Jun 2020

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 09 Jun 2020

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

By: GlobenewsWire - 08 Jun 2020

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial

By: GlobenewsWire - 04 Jun 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 03 Jun 2020

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

By: GlobenewsWire - 03 Jun 2020

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

By: GlobenewsWire - 02 Jun 2020

ORYZON to Present Additional Efficacy Clinical Data From ALICE Phase IIa Trial with Iadademstat at the 25th Congress of the European Hematology Association

By: GlobenewsWire - 02 Jun 2020

Related companies: Oryzon Genomics, S.A.

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

By: GlobenewsWire - 02 Jun 2020

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

By: GlobenewsWire - 02 Jun 2020

ORYZON Publishes Characterization and Mechanism of Action of Vafidemstat, a Phase II Clinical Stage LSD1 Inhibitor, in PLOS ONE

By: GlobenewsWire - 01 Jun 2020

Related companies: Oryzon Genomics, S.A.

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Sanofi announces closing of Regeneron stock sale

By: GlobenewsWire - 29 May 2020

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

By: GlobenewsWire - 29 May 2020

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 26 May 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 25 May 2020

Sanofi: information concerning the total number of voting rights and shares, April 2020

By: GlobenewsWire - 25 May 2020

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Catalonia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

September 2020
- Washington: The World Vaccine Congress Washington
- Brussels: The Pharma Business Development Course
October 2020
- Maryland Life Sciences Bio Innovation Conference

See Events »

Add an Event »

Latest company news

Availability of the Q3 2020 Memorandum for modelling purposes
25 Sep 2020 (GlobenewsWire)

World’s largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management
24 Sep 2020 (GlobenewsWire)

Allergy Therapeutics plc Preliminary Results for the year ended 30 June 2020
23 Sep 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial

Novo Nordisk A/S – Share repurchase programme

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

ORYZON to Present Additional Efficacy Clinical Data From ALICE Phase IIa Trial with Iadademstat at the 25th Congress of the European Hematology Association

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

ORYZON Publishes Characterization and Mechanism of Action of Vafidemstat, a Phase II Clinical Stage LSD1 Inhibitor, in PLOS ONE

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

Sanofi announces closing of Regeneron stock sale

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

Sanofi names new leaders to Executive Committee

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

Sanofi announces pricing of Regeneron stock offering

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, April 2020

Looking for companies outside of Catalonia?

Partners

Upcoming Life Sciences Events

Latest company news